Immunogenic pneumococcal protein and vaccine compositions thereof

Details for Australian Patent Application No. 2001255772 (hide)

Owner Medimmune, Inc

Inventors Amadou, John E.; Johnson, Leslie S.; Koenig, Scott

Agent Spruson & Ferguson

Pub. Number AU-B-2001255772

PCT Pub. Number WO01/81380

Priority 60200074 27.04.00 US

Filing date 27 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 29 June 2006

International Classifications

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

29 June 2006 Application Accepted

  Published as AU-B-2001255772

26 October 2006 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to MedImmune, LLC

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001255773

2001255771-Enzymes useful for treating and methods for treating MPS-VI and cell lines for producing such enzymes recombinantly